Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joon Ho Moon

Showing results (211-220 of 280) with videos related to

Pageof 28
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|May 8, 2019
Favorable Outcomes With Tumor Burden Reduction Following Administration of Hypomethylating Agents Before Allogeneic Hematopoietic Cell Transplantation in Patients With Higher Risk Myelodysplastic SyndromeSungwoo Park, Dong Won Baek, Sang Kyun Sohn, et al.
Annals of Hematology|August 18, 2016
Report on outcomes of hypomethylating therapy for analyzing prognostic value of Revised International Prognostic Scoring System for patients with lower-risk myelodysplastic syndromesYoo Jin Lee, Sung Woo Park, In Hee Lee, et al.
Experimental Neurobiology|September 27, 2014
Proposed Motor Scoring System in a Porcine Model of Parkinson's Disease induced by Chronic Subcutaneous Injection of MPTPJoon Ho Moon, Ji Ho Kim, Hyung-Jun Im, et al.
Annals of Hematology|March 19, 2010
Predictive value of pretreatment risk group and baseline LDH levels in MDS patients receiving azacitidine treatmentJoon Ho Moon, Shi Nae Kim, Byung Woog Kang, et al.
Blood Cell Therapy|January 30, 2023
The 2016 APBMT Activity Survey Report: Trends in haploidentical and cord blood transplantation in the Asia-Pacific regionMinako Iida, Anthony Dodds, Mafruha Akter, et al.
Annals of Hematology|December 23, 2015
Transplant outcomes of the triple-negative NPM1/FLT3-ITD/CEBPA mutation subgroup are equivalent to those of the favourable ELN risk group, but significantly better than the intermediate-I risk group after allogeneic transplant in normal-karyotype AMLJae-Sook Ahn, Hyeoung-Joon Kim, Yeo-Kyeoung Kim, et al.
Annals of Hematology|August 4, 2018
Response to hypomethylating agents improves long-term outcomes for lower-risk patients with myelodysplastic syndrome in case-matched cohortsDong Won Baek, Yoo Jin Lee, Hyunjeong Kim, et al.
The Korean Journal of Gastroenterology = Taehan Sohwagi Hakhoe Chi|October 26, 2005
[A case of retroperitoneal schwannoma of the vagus nerve]Byoung Kwan Yoo, Kyo Sang Yoo, Chul Sung Park, et al.
Cancer Medicine|December 2, 2016
Efficacy and toxicity of the combination chemotherapy of thalidomide, alkylating agent, and steroid for relapsed/refractory myeloma patients: a report from the Korean Multiple Myeloma Working Party (KMMWP) retrospective studyJihyun Kwon, Chang-Ki Min, Kihyun Kim, et al.
Scientific Reports|October 15, 2021
A beneficial role of computer-aided diagnosis system for less experienced physicians in the diagnosis of thyroid nodule on ultrasoundSunyoung Kang, Eunjung Lee, Chae Won Chung, et al.
Pageof 28

Showing results (211-220 of 280) with videos related to

Sort By:
Pageof 28
Clinical Lymphoma, Myeloma & Leukemia|May 8, 2019
Favorable Outcomes With Tumor Burden Reduction Following Administration of Hypomethylating Agents Before Allogeneic Hematopoietic Cell Transplantation in Patients With Higher Risk Myelodysplastic SyndromeSungwoo Park, Dong Won Baek, Sang Kyun Sohn, et al.
Annals of Hematology|August 18, 2016
Report on outcomes of hypomethylating therapy for analyzing prognostic value of Revised International Prognostic Scoring System for patients with lower-risk myelodysplastic syndromesYoo Jin Lee, Sung Woo Park, In Hee Lee, et al.
Experimental Neurobiology|September 27, 2014
Proposed Motor Scoring System in a Porcine Model of Parkinson's Disease induced by Chronic Subcutaneous Injection of MPTPJoon Ho Moon, Ji Ho Kim, Hyung-Jun Im, et al.
Annals of Hematology|March 19, 2010
Predictive value of pretreatment risk group and baseline LDH levels in MDS patients receiving azacitidine treatmentJoon Ho Moon, Shi Nae Kim, Byung Woog Kang, et al.
Blood Cell Therapy|January 30, 2023
The 2016 APBMT Activity Survey Report: Trends in haploidentical and cord blood transplantation in the Asia-Pacific regionMinako Iida, Anthony Dodds, Mafruha Akter, et al.
Annals of Hematology|December 23, 2015
Transplant outcomes of the triple-negative NPM1/FLT3-ITD/CEBPA mutation subgroup are equivalent to those of the favourable ELN risk group, but significantly better than the intermediate-I risk group after allogeneic transplant in normal-karyotype AMLJae-Sook Ahn, Hyeoung-Joon Kim, Yeo-Kyeoung Kim, et al.
Annals of Hematology|August 4, 2018
Response to hypomethylating agents improves long-term outcomes for lower-risk patients with myelodysplastic syndrome in case-matched cohortsDong Won Baek, Yoo Jin Lee, Hyunjeong Kim, et al.
The Korean Journal of Gastroenterology = Taehan Sohwagi Hakhoe Chi|October 26, 2005
[A case of retroperitoneal schwannoma of the vagus nerve]Byoung Kwan Yoo, Kyo Sang Yoo, Chul Sung Park, et al.
Cancer Medicine|December 2, 2016
Efficacy and toxicity of the combination chemotherapy of thalidomide, alkylating agent, and steroid for relapsed/refractory myeloma patients: a report from the Korean Multiple Myeloma Working Party (KMMWP) retrospective studyJihyun Kwon, Chang-Ki Min, Kihyun Kim, et al.
Scientific Reports|October 15, 2021
A beneficial role of computer-aided diagnosis system for less experienced physicians in the diagnosis of thyroid nodule on ultrasoundSunyoung Kang, Eunjung Lee, Chae Won Chung, et al.
Pageof 28